Multiple sclerosis.(Brief article)Santelli, Jeanine Seguin
This article has been updatedAbstract Multiple sclerosis (MS) is the most common chronic inflammatory, demyelinating and neurodegenerative disease of the central nervous system in young adults. This disorder is a heterogeneous, multifactorial, immune-mediated disease that is influenced by both genetic and...
Our incomplete understanding of the causes and pathways involved in the onset and progression of multiple sclerosis (MS) limits our ability to effectively treat this complex neurological disease. Recent studies explore the role of immune cells at differe
View article Glial Cell Types Conrad A.Messam, ...Eugene O.Major, inEncyclopedia of the Human Brain, 2002 III.D.1Multiple Sclerosis Multiple sclerosis(MS) is a major demyelinating disease with pathological features similar to those of the experimental animal model,experimental allergic encephalomyelit...
View article Multiple Sclerosis; Diagnosis R.K.Shin, inEncyclopedia of the Neurological Sciences (Second Edition), 2014 Secondary Progressive Multiple Sclerosis After years of RRMS, some MS patients begin to accumulate gradually progressive disability, typically slowly worsening gait impairment and incoordi...
Multiple sclerosis (MS) is a chronic disease characterized by loss of myelin (demyelination) and damage to nerve fibers (neurodegeneration) in the central nervous system (CNS). MS is associated with a diverse range of physical, cognitive, emotional, and behavioral symptoms, and can significantly ...
736 article google scholar crossref 70. rao smleo gjhaughton vwst. aubin-faubert pbernardin l correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis. neurology. 1989;39161- 166 google scholar crossref 71. franklin gmheaton rknelson lmfilley cmseibert c ...
Scientists have created monolayers of myelin basic protein (MBP), a key component of the protective myelin sheath that wraps around nerve cells. This protein can act as a model for studying diseases such as multiple sclerosis
With Multiple Sclerosis Risk and Response to First-line Disease Modifying Drugs in Children Brenda Huppke, MD1; David Ellenberger, MSc2; Hannah Hummel, MD1; et al Wiebke Stark, MD1; Markus Röbl, MD1; Jutta Gärtner, MD1; Peter Huppke, MD1 Author Affiliations Article Information JAMA Neurol...
Article CAS PubMed Google Scholar Kermode AG, Thompson AJ, Tofts P, MacManus DG, Kendall BE, Kingsley DP, Moseley IF, Rudge P, McDonald WI: Breakdown of the blood–brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications...